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Abstract
Adrenalectomy in the mature rat leads to death of granule cells in the dentate gyrus of the
hippocampal formation. The mechanisms underlying this cell death have not been fully clarified:
It has been considered that the granule cells require adrenal steroids for their survival, since
corticosterone replacement prevents their death. However, adrenalectomy-induced loss of negative
feedback also increases levels of corticotropin releasing hormone (CRH) in several limbic brain
regions. CRH is known to induce neuronal death in hippocampal regions rich in CRH receptors.
This study tested the hypothesis that adrenalectomy-induced granule cell death is mediated via the
enhanced activation of CRH receptors. The extent of granule cell degeneration was compared
among 4 groups of young adult male rats: Sham-adrenalectomy controls, adrenalectomized rats,
adrenalectomized rats infused with a CRH antagonist from the onset of steroid deprivation to the
time of sacrifice, and adrenalectomized rats infused with vehicle only. (9–41)-alpha-helical CRH
was administered using an osmotic pump into the cerebral ventricles. Adrenalectomy led to robust
granule cell degeneration, which was maximal in the suprapyramidal blade of the dentate gyrus.
Infusion of the CRH antagonist in doses shown to block CRH actions on limbic neurons did not
decrease the number of degenerating granule cells compared with the untreated or vehicle-infused
adrenalectomized groups. Therefore, blocking the actions of CRH does not prevent
adrenalectomy-induced granule cell death, consistent with a direct effect of corticoids on the
survival of these neurons.
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INTRODUCTION
Adrenalectomy (ADX) of the adult rat leads to degeneration of a significant proportion of
granule cells in the dentate gyrus of the hippocampal formation (Sloviter et al., 1989;
Sloviter et al., 1993a,b). The structural features of this selective cell death are consistent
with apoptosis (Sloviter et al., 1993b), but the mechanisms activating this cell death are not
fully understood. Cell death commences within days of steroid withdrawal, and is clearly
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evident by 5–7 days (Gould et al., 1990; Hornsby et al., 1996). As adrenalectomy results in
depletion of steroids and selective steroid replacement prevents granule cell death (Joels and
deKloet, 1994; Hornsby, et al., 1996), it has been assumed that adrenal steroids are required
for survival of granule cells. However, adrenalectomy, via loss of negative feedback, also
increases the synthesis and levels of corticotropin releasing hormone (CRH; Vale et al.,
1981) in a number of limbic brain regions (Young et al., 1986; Makino et al., 1994). CRH
may play a pivotal role in ADX-induced death of dentate gyrus granule cells: First, previous
studies have shown that CRH administration to the immature rat can lead to cell death in the
hippocampal CA3 region, which is rich in CRH receptors during that developmental age
(Baram and Ribak, 1995); in the adult rat, the dentate gyrus contains higher levels of CRH
receptors (Avishai-Eliner et al., 1996). Next, CRH antagonists have been shown to protect
from ischemic and excitotoxic neuronal death (Lyons et al., 1991; Maecker et al., 1997).
Finally. CRH receptors and their messenger-RNA are abundant in the dentate gyrus of the
adult rat (De Souza et al., 1985; Potter et al., 1994; Avishai-Eliner et al., 1996), which may
provide a basis for the apparent selective loss of these cells after ADX.
The goal of this study was to test the hypothesis that ADX results in granule cell death via
excess activation of CRH receptors (Fig. 1). The hypothesis predicts that ADX-induced
granule cell loss is prevented by inhibiting activation of CRH receptors. Therefore, the
ability of a chronic infusion of a competitive CRH receptor antagonist to prevent ADX-
induced granule cell death was investigated.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley derived rats (125–150 gm) were purchased from Zivic-Miller
(Zelienople, PA). Rats were maintained (two per cage) in a NIH-approved animal facility,
kept on a 12-h light, 12-h dark cycle, and given access to unlimited lab chow and water.
ADX rats were offered saline, and all post-surgical rats received oral antibiotics in their
drinking solutions. Experiments were approved by the institutional committee for animal
care.
Experimental Design
Four experimental groups (n = 6 / group) were compared for the extent of granule cell death:
1) Sham-operated controls; 2) ADX rats 3) ADX rats who received CRH-antagonist via
infusion into the lateral cerebral ventricle from the onset of steroid deprivation to the time of
sacrifice (ADX-Antagonist), and 4) ADX rats infused with the vehicle for the antagonist
only (ADX-Vehicle). All ADX groups were permitted to recuperate for three days and were
provided with corticosterone (20 mg/liter) in their drinking solution. The ADX-Antagonist
and the ADX-Vehicle groups were then subjected to cannula- and micropump-implantation.
Corticosterone was withdrawn from the drinking solutions of all ADX groups on the
morning after the onset of CRH-antagonist or vehicle infusion, and all groups were
sacrificed 5–7 days later.
Surgical Procedures
a. ADX was performed in the morning, to prevent potential circadian variation in
CRH levels (Watts and Swanson, 1989), under halothane anesthesia, using a dorsal
approach. The completeness of the ADX was verified in each animal using two
methods: first, a postmortem inspection excluded visible adrenal tissue; second,
plasma corticosterone was measured to exclude ectopic steroid-secreting adrenal
tissue. Animals with evidence of incomplete ADX by either method were excluded
from further analysis.
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b. Implantation of osmotic micro-pumps: Following ADX, the ADX-Antagonist and
ADX-Vehicle groups received (9–41)-alpha-helical CRH antagonist and vehicle,
respectively, via an Alzet micro-pump (0.5 × 0.25″; ALZA Co., Palo Alto, CA).
Animals were anesthetized with halothane and secured in the stereotaxic apparatus
while a cannula was inserted into the lateral cerebral ventricle as previously
described (Baram and Schultz, 1991; Baram et al., 1992). A length of plastic tubing
connected to the cannula was threaded subcutaneously to the micro-pump which
was implanted dorsally at the shoulder area. The accurate placement of the cannula
was histologically verified for each animal.
CRH-antagonist and vehicle treatment—The inhibitory peptide analog (9–41)-alpha-
helical CRH (Rivier et al., 1984) was utilized. The peptide is a competitive antagonist at
both members of the CRH receptor family (CRF1 and CRF2). The peptide was dissolved in
saline at a concentration of 5 mg/ml and the osmotic pump was filled according to the
manufacturer’s instructions. The pumps were set to deliver 0.5 microliter per hour or 60 μg
per rat per day. The vehicle-infused control group received the same volume of saline.
Hormonal and physiological monitoring—Plasma corticosterone was determined by
radioimmunoassay using a commercial assay (ICN, Irvine, CA) as described previously
(Baram and Schultz, 1992). Assay sensitivity was 0.005 μg/dl. All animals were weighed at
the onset of the experiment and on the day of sacrifice.
Tissue Processing—Under pentobarbital anesthesia, animals were perfused
intracardially with saline for 5 minutes, followed by a fresh, buffered 4% paraformaldehyde
solution for 12 minutes. Brains were kept in situ for 24 hours, then removed, cryoprotected
in 25% sucrose, and stored at −80°C. Brains were cut into 20 μm coronal sections in a
cryostat, mounted on gelatin-coated slides and stored at 4°C.
Nissl Staining for visualization of apoptotic neurons—Coronal sections were
chosen to represent the septal, middle, and temporal regions of the hippocampus as
described below. Staining procedures employed 0.1% cresyl violet for 5–8 minutes. The
sections were immersed in distilled water containing 0.15% acetic acid (15 seconds)
followed by graded alcohols (70%, 80%, 95% containing 0.15% acetic acid, and 100%
twice) and finally cleared in Histoclear (Fisher Scientific) and coverslipped.
Quantitation of Apoptotic Granule Cells—Granule cells were examined for features
of apoptosis in both the ipsilateral and contralateral dentate gyrus to the side of cannula
placement and at all levels of the hippocampal formation as detailed below. Granule cells
were considered to be undergoing apoptosis based on morphological characteristics,
including a pyknotic, shrunken nucleus and an eosinophilic cytoplasm. For purposes of
quantitation, only cells that exhibited dense chromatin, forming crescent or ringlike
structures or discrete clumps, were counted (Fig. 2). Pyknotic single nuclear clumps were
excluded. Cells were not counted if their cytoplasm lay outside the boundary of the granule
cell layer, as defined by a line connecting the outside-most boundary of adjacent cells.
Analysis and statistical considerations—Only animals considered to have a complete
ADX were analyzed. Each animal was inspected for residual adrenal tissue after sacrifice,
and its plasma was subjected to corticosterone assay as described above. Animals with
visible residual adrenals and/or plasma corticosterone levels of >0.2 μg/dl were excluded
from analysis. Therefore, after exclusion of incompletely ADX rats, the hippocampi from
three each ADX, ADX-Antagonist and ADX-vehicle rats were analyzed. To avoid major
differences in variance, only three, randomly-selected sham-ADX controls were analyzed.
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The number of apoptotic cells was determined in distinct subregions of the dentate gyrus.
These included the infra-pyramidal and supra-pyramidal blades, from the septal (anterior),
middle, and temporal (caudal) regions of the hippocampal formation. The septal region of
the dentate gyrus corresponded to (−1.8 mm to −3 3 mm) posterior to Bregma (Plates 18–21,
Paxinos and Watson, 1986). The middle region encompassed (−3.8 to −4.8) posterior to
Bregma (Plates 22–24), while the temporal (posterior) region included plates 25–27 (−5.3 to
−6.3 mm) posterior to Bregma. A complete series of consecutive sections encompassing the
antero-posterior extent of the hippocampus was Nissl stained, and sections were screened to
determine the boundaries of the septal, middle, and temporal regions. The septal region.
1500 μm in length, averaged 75 (20 μm) sections, while the middle and temporal regions
averaged 50 sections each. For each rat, every tenth section in each region was analyzed,
leading to a mean of 10.92 ± 0.97 sections per rat (median 12 sections). Also, the left dentate
gyrus, contralateral to the cannula implantation was evaluated separately from the right,
ipsilateral side.
The significance of differences among the experimental groups was determined using the
appropriate statistical tests: For comparing Gaussian-distribution parameters (weight, plasma
corticosterone) of each experimental group to the control, student’s t-test (with Welch’s
correction, if appropriate) was used. For multiple group analysis, non-parametric (Kruskal-
Wallis) ANOVA with post-hoc Dunn’s test were utilized (e.g., Table III) using the PRISM
software package, (San Diego, CA).
RESULTS
ADX led to drastic reduction of plasma corticosterone levels (a mean of 0.08 μg/dl in the
three ADX groups, compared with 2.8 μg/dl in controls), and to a decreased body weight
gain (Table 1). Animals carrying the Alzet-pump (ADX-Antagonist and ADX-Vehicle
groups) gained less weight than those subjected to ADX alone, potentially because of the
added surgical stress.
ADX resulted in significant numbers of apoptotic neurons in the granule cell layer of the
dentate gyrus (Fig. 2). The distribution of these cells was not random and demonstrated a
distinct pattern. A higher number of degenerating cells were found in the suprapyramidal
blade, as compared with the infrapyramidal blade of the dentate gyrus (171 versus 79 in a
sampling of nine sections from a typical rat), as is shown in Table II (see also Fig. 3).
Administration of 60 μg per day of (9–41)-alpha-helical CRH did not alter the number of
apoptotic cells (Tables III and IV). Specifically, when compared to either ADX alone, or to
ADX and vehicle infusion, administration of CRH antagonist did not reduce the number of
apoptotic granule cells in any region of the dentate gyrus. To avoid missing a local
protective effect of the antagonist in regions close to the site of infusion, the number of
apoptotic cells was analyzed in several ways. First, both ipsilateral and contralateral sides of
the dentate gyrus, (septal, middle, and temporal) were compared among the experimental
groups (Table III). Next, since the side ipsilateral to the cannula may have been exposed to
higher antagonist concentrations, the left and right sides of the dentate gyrus were analyzed
separately, and the three most anterior sections, closest to the cannula site, were compared
among groups (Fig. 3). Also, since the infra-pyramidal blade may be closer to the CRH
antagonist infused into the lateral ventricle, these two blades were analyzed separately (Fig.
3; Table IV). Finally, whether the region closest to the site of infusion—the infra-pyramidal
dentate gyrus blade in the anterior, septal region—preferentially manifested fewer apoptotic
granule cells in the antagonist treated group in comparison to the control groups was
evaluated as well (Table IV). No trend for decreased numbers of apoptotic granule cells in
areas closer to the cannula was established (Fig. 3; Table IV).
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DISCUSSION
This study demonstrates that ADX for 5–7 days leads to the death of significant numbers of
dentate gyrus granule cells, which is not prevented by a competitive CRH antagonist,
suggesting that this death is not mediated by corticotropin releasing hormone (Fig. 1).
The model of ADX-induced cell death has been described in detail previously (Sloviter et
al., 1993a; Sloviter et al., 1993b). The original authors commented on the significant
variability, both qualitative and quantitative, in the number and distribution of apoptotic
neurons. In this study, we attempted to control as fully as possible for inter-animal
variability and the extent of steroid deprivation. First, young males were used (Joels, M,
personal communication), which minimized age and sex variability. Second, ADX was
performed in our lab and each animal was inspected postmortem. Third, animals were
monitored for weight gain (Table 1), since ADX typically leads to retarded growth. Finally,
corticosterone assays were performed and rats with residual levels above 0.2 μg/dl were
excluded from the study. This low level of residual corticosterone is similar to that reported
by McNeill et al., 1991, and is far lower than levels which “protect” from granule cell loss
(one μg/dl, Hornsby et al., 1996). The residual corticosterone levels permitted in the current
study are also lower than those which suppress adrenalectomy-induced upregulation of CRH
levels in the hypothalamus (Swanson and Simmons, 1989; Baram and Schultz, 1992).
The pattern of distribution of apoptotic granule cells found in young male Sprague-Dawley
rats in this study is in overall agreement with previous reports using Long-Evans (Sloviter et
al., 1993a) and Wistar rats (Hornsby et al., 1996). The supra-pyramidal blade of the dentate
gyrus contained more apoptotic neurons than the infra-pyramidal blade (Table II). As did
Sloviter et al., and Hornsby et al., we observed a tendency towards congregation of
apoptotic cells closer to the molecular layer. This is consistent with the preferential ADX-
induced death of “older” granule cells (Cameron and Gould, 1996). As far as the
rostrocaudal distribution of the apoptotic granule cells, our short-term ADX study suggested
a slight predominance of affected neurons posteriorly (Table II). Sloviter et al., using a
longer ADX period, found more dying granule cells in the septal region, while Jaarsma et
al., (1992) suggested that the middle third of the hippocampus was predominantly involved.
Although the ADX-induced granule cell death model has been amply described, the precise
mechanisms leading to the almost exclusive loss of granule cells are not clear. For example,
ADX results in loss of a number of different steroids, which exert their effects through two
distinct receptors (Reul and de Kloet, 1985; Joels and de Kloet. 1994). ADX also leads to
elimination of a major source of cate-cholamines. Because administration of corticosterone
prevents ADX-induced cell loss (Sloviter et al., 1989; Gould et al., 1990), it has been
assumed that lass of steroids constitutes the major feature of ADX which promotes granule
cell death. However, since the adrenal steroids have almost ubiquitous actions, drastic
reduction of their plasma levels is expected to initiate a complex cascade of “disinhibitory”
events. One of the more obvious effects of elimination of the negative feedback of
glucocorticoids within the central nervous system is up-regulation of the synthesis and levels
of the major stress-neurohormone, CRH. As early as 1985, ADX has been shown to increase
steady-state CRH-mRNA levels in the hypothalamus (Jingami et al., 1985; Young et al.,
1986). Increased levels of the CRH peptide itself were documented using both
radioimmunoassay (Moldow and Fischman, 1982) and immunocytochemistry (Kovacs et al.,
1986; Sawchenko, 1987) The regulatory effect of glucocorticoids on CRH synthesis has
been found in both the hypothalamus and the amygdala (Kovacs et al., 1986; Makino et al.,
1994). That this increase in CRH synthesis is due to blocking of the effects of adrenal
glucocorticoids on their receptors has also been established (Kovacs et al., 1986;
Sawchenko, 1987; Yi et al., 1993).
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CRH has been shown to lead to excitation of hippocampal neurons (Aldenhoff et al., 1983;
Baram et al., 1992; Smith and Dudek, 1994; Hollrigel et al., 1997). Administration of
picomole doses of CRH may lead to neuronal death in the hippocampus of the immature rat
(Baram and Ribak, 1995; Ribak and Baram. 1996). On ultrastructural analysis, the CRH-
induced cell death is characterized by the morphological features of apoptosis (Ribak and
Baram, 1996). Although (CRH seems to increase glutamate release in the hippocampus
(Hollrigel et al., 1997). the excitotoxic effect of CRH does not depend on glutamate receptor
activation (Baram et al., 1995) and is most likely mediated by CRF1, (Baram et al., 1997). In
the immature rat (second postnatal week) the neurons affected by CRH have consisted of
pyramidal cells of the CA3 region. This may well be due to the exceptionally high
abundance of CRH receptors, specifically the CRF1, type, in this region during development
(Avishai-Eliner et al., 1996). In the adult rat, the pattern of CRH receptor distribution in the
hippocampus differs, with elevated CRF1, concentration in the dentate gyrus (Wong et al.,
1994; Chalmers et al., 1995; Avishai-Eliner et al., 1996).
Competitive blockers of CRH receptors have been shown to decrease ischemic neuronal loss
(Lyons et al., 1991) and excitotoxic hippocampal cell death (Maecker et al., 1997),
implicating CRH in these processes of neuronal death. A potential mechanism by which
CRH could lead to neuronal death may involve increased intracellular calcium (Kuryshev et
al., 1996; Weiss et al., 1996). An ADX-induced cell death which is mediated via “excess”
activation of CRH receptors at sites of their high concentration would thus provide an
explanation for the unique specificity of this phenomenon to the granule cells of the dentate
gyrus.
The study described demonstrated that infusion of (9–41)-alpha-helical CRH, a competitive
analog of CRH, did not block ADX-induced cell death. The antagonist was infused into the
lateral cerebral ventricles (icv). and it could be argued that due to an insufficient dose or
limited diffusion the antagonist did not reach CRH receptors on the granule cells in adequate
concentrations. This possibility is considered remote for several reasons:
First, although distinct effects of CRH require different molar ratios of antagonist for their
attenuation (Fisher et al., 1991 ). the doses of (9–41 )-alpha-helical CRH needed for
complete abolishment of the excitatory effects of CRH on limbic neurons have been
established (Baram and Schultz, 1991; Baram et al., 1996). The molar ratio of (9–41)-alpha-
helical CRH: CRH leading to elimination of CRH-induced seizures was 12:1 (Baram and
Schultz, 1991). An additional study demonstrated that a ten-fold excess of the antagonist
given icv abolished CRH-induced neuronal excitation in 33% of rats and markedly
attenuated excitation in the remainder (Baram et al., 1996). Although the precise amounts of
native CRH in the hippocampus are unknown, total forebrain content of CRH is in the low
nanogram range (Palkovits et al., 1985). A daily delivery of 60 μg of CRH antagonist thus
provides at least one thousand-fold excess. Furthermore, protection of hippocampal neurons
from transient forebrain ischemia-induced death was observed even with (9–41)-alpha-
helical CRH doses of 1 and 10 μg given icv (Lyons et al., 1991)
Second, the extent of diffusion of the antagonist to sites of CRH action may be a concern.
However, earlier studies (Baram and Schultz, 1991; Baram et al., 1992) have documented
that CRH-induced seizures originated in the amygdala, and that amygdala-origin behavioral
seizures and epileptic electroencephalographic discharges were eliminated by the icv
administered CRH antagonist. This provides strong evidence that the alpha-helical CRH
reaches the amygdala, which is significantly further from the cerebral ventricles than the
dentate gyrus. Similar effects of (9–41)-alpha-helical CRH on amygdala-mediated
parameters of anxiety and stress-behaviors have been published by others (Heinrichs et al.,
1992).
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Additionally, if issues of antagonist concentration. due to insufficient quantity or penetration
problems. were the cause for the observed lack of protection against ADX-induced granule
cell death, a local protective effect around the cannula site or an alteration of the distribution
pattern of the granule cell loss would be expected. As is evident from Tables III and IV and
from Figure 3, no decrease in the number of apoptotic granule cells was found anteriorly
(septally, closest to the site of cannula implantation) in rats treated with the CRH antagonist.
Similarly, no reduction of the number of apoptotic cells ipsilateral to the cannula was
observed.
These data lead to the conclusion that the tested hypothesis–that ADX-induced apoptosis of
dentate gyrus granule cells is mediated by CRH receptor activation—is not correct. Refuting
this hypothesis leaves open the ongoing quest for the molecular mechanisms leading from
elimination of the adrenal gland to the specific death of a unique population of limbic
neurons (Hornsby et al., 1996). Issues under consideration include the “permissive” role of
low steroid levels for neuronal survival as opposed to the well established degeneration
induced by high steroid levels (McEwen et al., 1992). Other unresolved issues awaiting both
theoretical and experimental approaches include the basis for the specificity of the observed
neuronal death to the granule cells which are not particularly rich in either mineralocorticoid
or glucocorticoid receptors, and the relative importance of other factors such as glutamate-
mediated neurotransmission (Magarinos and McEwen, 1995).
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FIGURE 1.
A cartoon illustrating several potential mechanisms for the death of granule cells after
adrenalectomy. The top illustration demonstrates the situation in an intact animal. Granule
cells are shown to possess receptors for corticotropin releasing hormone (CRH), as well as
the two types of steroid receptors: mineralocorticoid (MR) and glucocorticoid (GR). The
occupancy of these receptors under these “normal” circumstances is depicted. The two
bottom illustrations demonstrate two alternative scenarios for granule cell death. On the left,
a marked excess of CRH. due to elimination of the negative feedback action of adrenal
steroids, leads to activation of CRH receptors (CRH-R) and to excitotoxicity. Alternatively,
as shown on the right, absence of adrenal steroid ligands for the MR receptors interferes
with cell survival. B = corticosterone.
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FIGURE 2.
A composite showing the dentate gyrus and a photomicrograph of a granule cell in the
granule cell layer of a male rat adrenalectomized 5 days prior to sacrifice. The cell displays
the morphological features of apoptosis. i.e., clumping of the chromatin. Nissl stain, 1000x
prior to reduction.
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FIGURE 3.
A graph showing the numbers of apoptotic granule cells in the septal (anterior) region of the
dentate gyrus of four experimental groups. The three most anterior. sections from each
animal were subjected to counting of apoptotic cells as described in the Methods section.
The septal region is the closest to the site of cannula placement and thus to the maximal
concentration of the CRH-antagonist infused via the cannula. Values are means ± S.E.M. of
9 sections per group. For each of the four regions, experimental groups are significantly
different (p=0.0028 – 0.014; Kruskal-Wallis test). The apoptotic cell numbers of the three
ADX groups (ADX alone, or with infusion of vehicle or CRH antagonist) are not
significantly different from each other (p > 0.05; Dunn’s multiple comparisons post-hoc
test). Abbreviations: INF = infra-pyramidal; SUP = suprapyramidal: IPSI = ipsilateral to the
cannula (right); CONTRA = contralateral to the cannula (left).
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TABLE I
Hormonal and physiological parameters of Sham-adrenalectomized (ADX), ADX and ADX-rats treated with
the CRH antagonist, (9–41)-alpha-helical CRH or with the saline vehicle
Treatment group Weight gain (gm) plasma corticosterone
(μg/dl)
Control 46.5 ± 0.5 2.8 ± 0.23
ADX 25.0 ± 5.0+ 0.09 ± 0.02*
ADX+ Antagonist 15.3 ± 2.9+ 0.06 ± 0.02*
ADX+ Vehicle 14.7 ± 7.8+ 0.09 ± 0.04*
Control rats were sham-ADX. All the ADX rats were given corticosterone for three days. On the fourth day the ADX-antagonist and ADX-vehicle
groups underwent cannula implantation in the cerebral lateral ventricle, which was connected to a subcutaneously implanted osmotic micropump
(Alza). Animals were sacrificed 5–7 days later. Weight gain was defined as the difference between the animals’ weight on the day of sacrifice and
on the day of elimination of corticosterone from the drinking water.
+Significantly different from the sham-adrenalectomy control group (p < 0.01).
*Significantly different from the control group (p < 0.0001, Student’s t-test with Welch’s correction).
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TABLE III
Effect of CRH antagonist infusion on ADX-induced granule cell death
Treatment:
Dentate Gyrus Region
Septal Middle Temporal
Sham-ADX 0.67 ± 0.2 0.38 ± 0.7 0.66 ± 0.33
ADX 10.7 ± 1.6* 17.0 ± 3.9* 15.0 ± 3.2*
ADX-Antagonist 9.0 ± 1.4* 22.4 ± 7.0* 28.8 ± 18.1*
ADX-Vehicle 16.3 ± 1.8* 18.1 ± 2.1* 22.4 ± 3.9*
The number of apoptotic granule cells was determined in both the left and the right side of the dentate gyrus. The number of sections and the
anatomic boundaries of the septal, middle, and temporal regions of the hippocampal formation have been defined in the Methods’ section.
*
Treatment group medians are significantly different from the control group’s (p < 0.05; Kruskal-Wallis non-parametric ANOVA test). ADX-
Vehicle is not significantly different from ADX-Antagonist (post-hoc Dunn’s test).
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TABLE IV
Comparison of apoptotic cell number in the infra-pyramidal and supra-pyramidal blades of the septal dentate
gyrus in adrenalectomized (ADX) rats infused with CRH antagonist compared with sham-ADX, ADX alone
and ADX rats infused with vehicle
Treatment: Infra-pyramidal Supra-pyramidal
Sham ADX 0.7±0.26 0.6±0.30
ADX 2.1±0.34 3.2±0.53
ADX-Antagonist 2.7±0.39 7.2±3.10
ADX-Vehicle 2.8±0.44 4.9±0.79
The values are means ± S.E.M. of apoptotic cells counted in both the left and right dentate gyrus, in the three most anterior sections of each of three
rats per group within the septal region of the hippocampal formation. The anterior septal region was chosen since it is the closest to the cannula
site. The infra-pyramidal blade, which is closer to the cerebral lateral ventricle, is compared to the suprapyramidal blade, to look for a local
protective effect of the CRH antagonist against ADX-induced granule cell death. For both the inferior and the superior blades, experimental group
medians arc significantly different (p < 0.0004; Kruskal-Wallis nonparametic ANOVA test). Post-hoc Dunn’s multiple comparison test reveals a
significant difference between the control and each of the ADX groups, but no significant difference among the three ADX groups.
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